Christopher Gallardo

Christopher Gallardo, PhD, is a seasoned professional in the medical science liaison field, currently serving as a Senior Medical Science Liaison at Intra-Cellular Therapies since April 2024. Previously, Christopher held similar roles at Neurelis, Inc. and Pfizer, where responsibilities included supporting therapeutic areas for epilepsy and migraine, respectively. Christopher's career includes significant contributions as Associate Director and Associate Medical Science Liaison at Biohaven Pharmaceuticals and AbbVie, focusing on neurological treatments and ensuring the successful launch of key products. Academic credentials include a PhD in Pharmacology from the University of Minnesota, complemented by earlier research and educational roles at prestigious institutions. Christopher's expertise spans various neurological and psychiatric disorders, underpinned by active participation in the development of educational and scientific resources for the medical community.